Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Europe & Central Asia (excluding high income)
Europe & Central Asia (excluding high income): Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and was 14.5% in 2021. ▼ Falling
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Europe & Central Asia (excluding high income), 2000–2021
Source: World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Measured in %.
Analysis
Europe & Central Asia (excluding high income) recorded 14.5% for mortality from cvd, cancer, diabetes or crd between exact ages 30 and in 2021. That is the lowest value across all 22 years on record.
The figure is down 0.1% on the previous year and down 20.8% over ten years.
Over the whole period, mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Europe & Central Asia (excluding high income) peaked at 23.0% in 2000 and was at its lowest, 14.5%, in 2021.
Europe & Central Asia (excluding high income) ranks 29th of 47 groups on this measure, in the middle of the range.
The long-run direction has been consistently falling across the 22 years of available data.
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Europe & Central Asia (excluding high income), year by year
| Year | % | Change |
|---|---|---|
| 2000 | 23.0% | — |
| 2001 | 22.3% | -2.8% |
| 2002 | 22.2% | -0.5% |
| 2003 | 22.1% | -0.7% |
| 2004 | 21.6% | -2.1% |
| 2005 | 21.7% | +0.6% |
| 2006 | 21.0% | -3.2% |
| 2007 | 20.5% | -2.8% |
| 2008 | 20.1% | -2.0% |
| 2009 | 19.4% | -3.3% |
| 2010 | 19.0% | -2.0% |
| 2011 | 18.3% | -3.9% |
| 2012 | 17.7% | -3.3% |
| 2013 | 17.0% | -3.9% |
| 2014 | 16.9% | -0.6% |
| 2015 | 16.2% | -4.0% |
| 2016 | 15.9% | -1.5% |
| 2017 | 15.5% | -2.7% |
| 2018 | 15.2% | -1.9% |
| 2019 | 14.8% | -2.5% |
| 2020 | 14.5% | -2.4% |
| 2021 | 14.5% | -0.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 21.4% | 19.4% | 23.0% | 10 |
| 2010s | 16.6% | 14.8% | 19.0% | 10 |
| 2020s | 14.5% | 14.5% | 14.5% | 2 |
Countries ranked near Europe & Central Asia (excluding high income)
More health data for Europe & Central Asia (excluding high income)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, male, annual growth rate 2.65 % change on previous year (2025)
- Population ages 45-49, female, per capita 0.0335 units per person (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per capita 0.0381 units per person (2025)
- Population ages 45-49, female, annual growth rate 2.23 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0363 units per person (2025)
- Population ages 40-44, female, annual growth rate 1.72 % change on previous year (2025)
- Population ages 10-14, male, per unit of GDP 0 units per US$ of GDP (2025)
All data for Europe & Central Asia (excluding high income) →
Frequently asked questions
- What is mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Europe & Central Asia (excluding high income)?
- Mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Europe & Central Asia (excluding high income) was 14.5% in 2021, according to World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO).
- What is the highest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Europe & Central Asia (excluding high income)?
- The highest recorded value was 23.0% in 2000.
- What is the lowest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Europe & Central Asia (excluding high income)?
- The lowest recorded value was 14.5% in 2021.
- How does Europe & Central Asia (excluding high income) rank for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
- Europe & Central Asia (excluding high income) ranks 29th out of 47 groups with data for 2021.
- Is mortality from cvd, cancer, diabetes or crd between exact ages 30 and rising or falling in Europe & Central Asia (excluding high income)?
- Over the last ten years it is down 20.8%. The long-run trend across the full record is falling.
- Where does this Europe & Central Asia (excluding high income) data come from?
- The figures come from World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as part of Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 22 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).